Clinical Trial

Adaptive Trial Scheduling in Naming Treatment for Aphasia

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Aphasia is a language disorder caused by stroke and other acquired brain injuries that affects over two million people in the United States and which interferes with life participation and quality of life. Anomia (i.e., word- finding difficulty) is a primary frustration for people with aphasia. Picture-based naming treatments for anomia are widely used in aphasia rehabilitation, but current treatment approaches do not address the long-term retention of naming abilities and do not focus on using these naming abilities in daily life. The current research aims to evaluate novel anomia treatment approaches to improve long-term retention and generalization to everyday life. This study is one of two that are part of a larger grant. This record is for sub-study 2, which will evaluate the benefits of adaptive trial spacing.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2022-12-07; most recent amendment 2025-12-05.
Status change: Not Yet Recruiting → Recruiting 2023-09-26
Trial Details
NCT Number NCT05653466
Lead Sponsor University of Pittsburgh
Collaborators: University of Massachusetts, Amherst, National Institute on Deafness and Other Communication Disorders (NIDCD)
Conditions Aphasia, Stroke
Enrollment 32 participants
Start Date 2023-12-06
Primary Completion 2027-01-31 (estimated)
Study Completion 2028-01-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-11